# Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study

> **NCT04718792** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Anders Fink-Jensen, MD, DMSci** · enrollment: 10 (actual)

## Conditions studied

- Alcohol Use Disorder (AUD)

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT04718792
- **Lead sponsor:** Anders Fink-Jensen, MD, DMSci
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-09
- **Primary completion:** 2024-07-21
- **Final completion:** 2024-07-21
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04718792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04718792, "Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04718792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*